← Evidence map

ArticleScience (New York, N.Y.)2025

Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity.

Douglas R Wassarman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40997174